Dermatology
Latest News
Beware the hidden allergens in nutritional supplements
A detailed history of supplement use is important, as it may reveal possible allergens as the cause of previously unidentified reactions.
From the Journals
Study focuses on adolescent data in upadacitinib AD trials
Upadacitinib was generally well tolerated among the adolescents, with mild or moderate acne being the most common adverse event.
Pediatric Dermatology Consult
A 7-month-old male presents with pustules and inflamed papules on the scalp and extremities
A 7-month-old male presents with pustules and inflamed papules on the scalp and extremities.
Latest News
USPSTF releases updated recommendations on skin cancer screening
“Our recommendations are for patients who present to primary care without symptoms, and after a careful assessment of benefit and harms, we didn’t...
Latest News
Study compares noninvasive treatments of cutaneous neurofibromas
The epidermis overlying cNF is normal, “so there is no reason to use nonselective or surgical methods and destroy a perfectly good epidermis when...
Latest News
The earlier baricitinib for severe alopecia areata is started, the better
“If I can keep someone on 4 mg that’s great, but it looks like you can go to a lower dose and do a pretty good job,” Dr. Raj Chovatiya said.
Latest News
What are the clinical implications of recent skin dysbiosis discoveries?
Activities that can contribute to alterations in skin flora or skin dysbiosis include topical application of steroids, antibiotics, retinoids,...
Latest News
Frustration over iPLEDGE evident at FDA meeting
Dermatologists argue the iPLEDGE REMS burden is too high for providers and patients. Access problems persist with lockouts and some cite a lack of...
Feature
Biosimilars and patients: Discussions should address safety, cost, and anxiety about change
Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and...
Latest News
FDA panels vote to modify isotretinoin iPLEDGE REMS
The committees sought to balance reducing burden with maintaining safety and preventing fetal exposures to isotretinoin.
Latest News
FDA Advisory panels consider easing isotretinoin requirements
The 2-day meeting is addressing what can be done to reduce burden with the iPLEDGE REMS while maintaining safety and preventing fetal exposure to...